Addiction Audio4 Apr 2024

Synthetic opioid production in Europe with Paul Griffiths

In this episode, Dr Elle Wadsworth talks to Paul Griffiths about synthetic drug production in Europe including the differences between lab-made substances and diverted medical drugs. They discuss organised crime and its impact on cocaine production, drug availability and the potential for drug contamination. They also cover fentanyl and the potential for a heroin drought resulting from changes in opium production in Afghanistan.

Paul talks about the complexities of European drug markets explaining how they commonly respond to changes in both supply and demand. Elle and Paul then discuss how researchers can monitor drug trends through wastewater analysis and other methods.

“These are often very small labs, but because of the potency of these drugs, it means very small production runs can have quite a big impact on local drug consumption patterns and mortality and morbidity. So we saw a few years ago, ten or fifteen years, one lab in central Europe we had a very brief outbreak of deaths in about three countries all related to a very very small, a kitchen lab it was actually in someone’s kitchen but it had an impact.”

Paul Griffiths is the scientific director for the EMCDDA – the European Monitoring Centre for Drugs and Drug Addiction

Original article: Opioid problems are changing in Europe with worrying signals that synthetic opioids may play a more significant role in the future by Paul Griffiths and colleagues. Published in Addiction (2024)

The opinions expressed in this post reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

Hosted on Acast. See acast.com/privacy for more information.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(127)

How cognition and decision-making processes shape behaviour with Justin Mahlberg

In this episode, Dr Tsen Vei Lim speaks to Dr Justin Mahlberg, a Research Fellow at Monash University, Australia. The interview covers Justin’s research article on social cognition and decision-making...

16 Jan 20min

Drug-related deaths in the LGBTQ+ community with Emmert Roberts

In this episode, Dr Elle Wadsworth talks to Dr Emmert Roberts, Senior Clinical Lecturer at the National Addiction Centre, King’s College London and a Consultant Addiction Psychiatrist at the South Lon...

12 Des 202520min

Defining medical cannabis with Myfanwy Graham

In this episode, Dr Elle Wadsworth talks to Dr Myfanwy Graham, a Postgraduate Scholar at Monash University funded by the Australian Government's National Health and Medical Research Council. The inter...

5 Des 202513min

Health claims about US cannabis products with Tim Mackey and Doug Roehler

In this episode, Dr Elle Wadsworth talks to Dr Tim Mackey and Dr Doug Roehler. Tim is a professor in the Global Health Program at UC San Diego and the CEO and co-founder of S-3 Research, and Doug is t...

28 Nov 202521min

A smartphone app for reducing alcohol use with Joshua Garfield

In this episode, Dr Tsen Vei Lim speaks to Dr Joshua Garfield, a research fellow at Monash University and Turning Point, Australia. The interview covers Joshua’s research article on the efficacy of a ...

21 Nov 202515min

What wastewater reveals about drug use in Hanoi, Vietnam with Phong Thai

In this episode, Dr Elle Wadsworth talks to Dr Phong Thai, an Associate Professor at Queensland Alliance for Environmental Health Sciences, Australia. The interview covers Phong’s research article on ...

14 Nov 202517min

MDMA, anxiety, and depression with Zachary Bryant

In this episode, Dr Tsen Vei Lim talks to Zachary Bryant, a PhD candidate at the Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Australia. The interview covers Z...

31 Okt 202517min

Retention in buprenorphine treatment with Albert Burgess-Hull

In this episode, Dr Elle Wadsworth talks to Dr Albert Burgess-Hull, the Scientific Director of SUDx and Head Data Scientist at MATClinics, US. The interview covers a short report examining treatment r...

24 Okt 202516min